74
Views
10
CrossRef citations to date
0
Altmetric
Menopause

Hyperglycemia in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaints

, , , &
Pages 86-92 | Received 24 Feb 2009, Accepted 14 Jul 2009, Published online: 09 Nov 2009

References

  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 2002;287:356–359.
  • Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69–e171.
  • Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22:447–454.
  • Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the study of women's health across the nation. Arch Intern Med 2008;168:1568–1575.
  • Cho GJ, Lee JH, Park HT, Shin JH, Hong SC, Kim T, Lee KW, Park YK, Kim SH. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524–529.
  • Rossi R, Nuzzo A, Origliani G, Modena MG. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. Hypertension 2008;52:865–872.
  • Llaneza P, Iñarrea J, Gonzalez C, Alonso A, Arnott I, Ferrer-Barriendos J. Differences in health related quality of life in a sample of Spanish menopausal women with and without obesity. Maturitas 2007;58:387–394.
  • Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007;56:45–53.
  • Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gynecol Obstet 2007;275:161–168.
  • Laferrère B, Zhu S, Clarkson JR, Yoshioka MR, Krauskopf K, Thornton JC, Pi-Sunyer FX. Race, menopause, health-related quality of life, and psychological well-being in obese women. Obes Res 2002;10:1270–1275.
  • Juliá-Mollá MD, García-Sánchez Y, Romeu Sarrió A, Pérez-López FR. Cimicifuga racemosa treatment and health related quality of life in postmenopausal Spanish women. Gynecol Endocrinol 2009;25:21–26.
  • Castelo-Branco C, Palacios S, Ferrer-Barriendos J, Cancelo MJ, Quereda F, Alberich X. The Cervantes study group. Impact of anthropometric parameters on quality of life during menopause. Fertil Steril, in press.
  • Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D. The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res 2005;17:224–226.
  • Ponholzer A, Temml C, Rauchenwald M, Marszalek M, Madersbacher S. Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? Int J Impot Res 2008;20:100–104.
  • Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R, Cobellis L, De Sio M, Colacurci N, Giugliano D. Association of body weight with sexual function in women. Int J Impot Res 2007;19:353–357.
  • Doumas M, Tsiodras S, Tsakiris A, Douma S, Chounta A, Papadopoulos A, Kanellakopoulou K, Giamarellou H. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens 2006;24:2387–2392.
  • McCall K, Meston C. Differences between pre- and postmenopausal women in cues for sexual desire. J Sex Med 2007;4:364–371.
  • Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: women's health initiative. Maturitas 2004;49:292–303.
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486–2497.
  • Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161–175.
  • Blumel JE, Castelo-Branco C, Binfa L, Gramegna G, Tacla X, Aracena B, Cumsille MA, Sanjuan A. Quality of life after the menopause: a population study. Maturitas 2000;34:17–23.
  • Chedraui P, Pérez-López FR, San Miguel G, Avila C. Assessment of sexuality among middle aged women using the female sexual function index. Climacteric 2009;12:213–221.
  • Chedraui P, Morales B, Hidalgo L. Depression and related risk factors among climacteric women Climacteric 2008;11:125.
  • Valadares AL, Pinto-Neto AM, Conde DM, Osis MJ, Sousa MH, Costa-Paiva L. The sexuality of middle-aged women with a sexual partner: a population-based study. Menopause 2008;15:706–713.
  • Dennerstein L. Sexuality, midlife, and menopause. Menopause 2008;15:221–222.
  • Pérez-López FR. The menopause. Madrid: Temas de Hoy; 1992.
  • Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, et al APHRODITE Study Team. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359:2005–2017.
  • Dennerstein L, Lehert P, Koochaki PE, Graziottin A, Leiblum S, Alexander JL. A symptomatic approach to understanding women's health experiences: a cross-cultural comparison of women aged 20 to 70 years. Menopause 2007;14:688–696.
  • Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the ‘true’ prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med 2008;5:777–787.
  • Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the menopause rating scale. Maturitas 2007;57:271–278.
  • Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors. JAMA 1999;281:537–544.
  • Heiman JR, Guess MK, Connell K, Melman A, Hyde JS, Segraves RT, Wyllie MG. Standards for clinical trials in sexual dysfunctions of women: research designs and outcomes assessment. J Sex Med 2004;1:92–97.
  • Khademi A, Alleyassin A, Amini M, Ghaemi M. Evaluation of sexual dysfunction prevalence in infertile couples. J Sex Med 2007;5:1402–1410.
  • Derogatis LR, Burnett AL. The epidemiology of sexual dysfunctions. J Sex Med 2008;5:289–300.
  • Dennerstein L, Guthrie JR, Hayes RD, DeRogatis LR, Lehert P. Sexual function, dysfunction, and sexual distress in a prospective, population-based sample of mid-aged, Australian-born women. J Sex Med 2008;5:2291–2299.
  • Zollner YF, Acquadro C, Schaefer M. Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res 2005;14:309–327.
  • Palacios S, Ferrer-Barriendos J, Parrilla JJ, Castelo-Branco C, Manubens M, Alberich X, Marti A. Health-related quality of life in the Spanish women through and beyond menopause. Development and validation of the Cervantes Scale. Med Clin (Barc) 2004;122:205–211.
  • Blumel JE, Castelo-Branco C, Cancelo MJ, Romero H, Aprikian D, Sarra S. Impairment of sexual activity in middle-aged women in Chile. Menopause 2004;11:78–81.
  • Yánez D, Castelo-Branco C, Hidalgo LA, Chedraui PA. Sexual dysfunction and related risk factors in a cohort of middle-aged Ecuadorian women. J Obstet Gynaecol 2006;26:682–686.
  • Blumel JE, Araya H, Riquelme R, Castro G, Sanchez F, Gramegna G. Prevalence of sexual dysfunction in climacteric women. Influence of menopause and hormone replace therapy. Rev Med Chil 2002;130:1131–1138.
  • Blümel JE, Leon-Leon P, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Flores D, Espinoza MT, Izaguirre H, et al Sexual dysfunction in Latin America: prevalence and risk factors. Climacteric 2008;11:175.
  • Royer M, Castelo-Branco C, Blumel JE, Chedraui PA, Danckers L, Bencosme A, Navarro D, Vallejo S, Espinoza MT, Gomez G, et al The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007;10:164–170.
  • Schreiner-Engel P, Schiavi RC, Vietorisz D, Smith H. The differential impact of diabetes type on female sexuality. J Psychosom Res 1987;31:23–33.
  • Newman AS, Bertelson AD. Sexual dysfunction in diabetic women. J Behav Med 1986;9:261–270.
  • Enzlin P, Mathieu C, Van Den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care 2003;26:409–414.
  • Mezones-Holguin E, Blümel JE, Huezo M, Vargas R, Castro J, Córdova W, Valenzuela G, Castelo-Branco C. Impact of diabetes mellitus on the sexuality of Peruvian postmenopausal. Gynecol Endocrinol 2008;24:470–474.
  • De Mattia G, Bravi MC, Laurenti O, Moretti A, Cipriani R, Gatti A, Mandosi E, Morano S. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications. Diabetes Res Clin Pract 2008;79:337–342.
  • Morano S. Pathophysiology of diabetic sexual dysfunction. J Endocrinol Invest 2003;26:65–69.
  • Musicki B, Burnett AL. Endothelial dysfunction in diabetic erectile dysfunction. Int J Impot Res 2007;19:129–138.
  • Torréns JI, Sutton-Tyrrell K, Zhao X, Matthews K, Brockwell S, Sowers M, Santoro N. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of women's health across the nation. Menopause 2009;16:257–264.
  • Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404–2411.
  • Weinberg ME, Manson JE, Buring JE, Cook NR, Seely EW, Ridker PM, Rexrode KM. Low sex hormone–binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006;55:1473–1480.
  • Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Ble A, Egan JM, Metter EJ, Abbatecola AM, et al Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. Am J Physiol Endocrinol Metab 2007;292:E353–E358.
  • Akin F, Bastemir M, Alkış E, Kaptanoglu B. SHBG levels correlate with insulin resistance in postmenopausal women. Eur J Internal Med 2008;20:162–167.
  • Dennerstein L, Lehert P. Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause 2004;11:778–785.
  • Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, et al SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.